| 发明名称 |
ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR. |
| 摘要 |
<p>The present invention relates to aryloxyethylamine compounds of the formula (I) and the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use of a compound of the formula (I) or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.</p> |
| 申请公布号 |
MX2008013114(A) |
申请公布日期 |
2008.10.21 |
| 申请号 |
MX20080013114 |
申请日期 |
2007.04.13 |
| 申请人 |
ABBOTT GMBH & CO. KG |
发明人 |
LILIANE UNGER;UDO LANGE;KARLA DRESCHER;ANDREAS HAUPT;ROLAND GRANDEL;SEAN COLM TURNER;WILFRIED-MARTIN BRAJE |
| 分类号 |
C07D213/76;A61K31/4439;A61K31/506;A61P25/16;A61P25/24;A61P25/28;C07D239/69 |
主分类号 |
C07D213/76 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
